CASE HISTORIES
Morganceutical has developed numerous collaborations with leading Companies in the Healthcare sector
0
Years
0
Collaborations
0
Products
0
AMs / REPs hired
0
General Practitioners contacted
0
Specialists contacted
WOULD YOU LIKE TO RECEIVE MORE INFORMATION?
leave us your contact details and we will contact you as soon as possible
CONTACT USSOME RELEVANT PHARMACEUTICAL PRODUCTS WE HAVE MANAGED
| Year (Morganceutical activity start) | Product typology | Sales volume (units/year) |
| 2010 | PPI Originator | 1,5 MM |
| 2014 | Alpha-blocker (prostatic hypertrophy) | 4,3 MM |
| 2015 | SSRI Originator | 2,3 MM |
| 2016 | Quinolone Originator | 1,2 MM |
| 2017 | Iron++, Folic Acid | 8,2 MM (total) |
| 2020 | LAMA | 1,7 MM |
| Typology | N. Collaborations |
| Big Pharma | 2 |
| Large Multinational Companies | 5 |
| Multinationals average turnover (30-120MM /year in Italy) | 9 |
| Multinational generic pharmaceutical companies with branded products | 2 |
| High turnover Italian companies | 4 |
| Others | 10 |
MAIN TYPES OF PARTNER COMPANIES
CASE HISTORY 1
CASE HISTORY 2
CASE HISTORY 3
CASE HISTORY 4 A
CASE HISTORY 4 B
